178 related articles for article (PubMed ID: 23077299)
1. Effect of complement on HIV-2 plasma antiviral activity is intratype specific and potent.
Özkaya Şahin G; Holmgren B; Sheik-Khalil E; da Silva Z; Nielsen J; Nowroozalizadeh S; Månsson F; Norrgren H; Aaby P; Fenyö EM; Jansson M
J Virol; 2013 Jan; 87(1):273-81. PubMed ID: 23077299
[TBL] [Abstract][Full Text] [Related]
2. Potent intratype neutralizing activity distinguishes human immunodeficiency virus type 2 (HIV-2) from HIV-1.
Ozkaya Sahin G; Holmgren B; da Silva Z; Nielsen J; Nowroozalizadeh S; Esbjörnsson J; Månsson F; Andersson S; Norrgren H; Aaby P; Jansson M; Fenyö EM
J Virol; 2012 Jan; 86(2):961-71. PubMed ID: 22072782
[TBL] [Abstract][Full Text] [Related]
3. Frequent intratype neutralization by plasma immunoglobulin a identified in HIV type 2 infection.
Özkaya Şahin G; Månsson F; Palm AA; Vincic E; da Silva Z; Medstrand P; Norrgren H; Fenyö EM; Jansson M
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):470-8. PubMed ID: 23088167
[TBL] [Abstract][Full Text] [Related]
4. Comparison of heterologous neutralizing antibody responses of human immunodeficiency virus type 1 (HIV-1)- and HIV-2-infected Senegalese patients: distinct patterns of breadth and magnitude distinguish HIV-1 and HIV-2 infections.
Rodriguez SK; Sarr AD; MacNeil A; Thakore-Meloni S; Gueye-Ndiaye A; Traoré I; Dia MC; Mboup S; Kanki PJ
J Virol; 2007 May; 81(10):5331-8. PubMed ID: 17301136
[TBL] [Abstract][Full Text] [Related]
5. Rare Detection of Antiviral Functions of Polyclonal IgA Isolated from Plasma and Breast Milk Compartments in Women Chronically Infected with HIV-1.
Tay MZ; Kunz EL; Deal A; Zhang L; Seaton KE; Rountree W; Eudailey JA; Heptinstall J; McRaven MD; Matias E; McGuire E; Yates NL; Perez LG; Montefiori DC; Overman RG; Hope TJ; Shen X; Kalilani L; Fouda GG; Tomaras GD; Permar SR
J Virol; 2019 Apr; 93(7):. PubMed ID: 30700599
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of HLA proteins incorporated by human immunodeficiency virus type 1 and assessment of neutralizing activity of anti-HLA antibodies.
Lakhashe SK; Thakar MR; Bharucha KE; Paranjape RS
J Virol; 2008 Jan; 82(1):428-34. PubMed ID: 17942547
[TBL] [Abstract][Full Text] [Related]
7. Absence of a clinical correlation for complement-mediated, infection-enhancing antibodies in plasma or sera from HIV-1-infected individuals. Multicenter AIDS Cohort Study Group.
Montefiori DC; Lefkowitz LB; Keller RE; Holmberg V; Sandstrom E; Phair JP
AIDS; 1991 May; 5(5):513-7. PubMed ID: 1863402
[TBL] [Abstract][Full Text] [Related]
8. Evolution of human immunodeficiency virus type 2 coreceptor usage, autologous neutralization, envelope sequence and glycosylation.
Shi Y; Brandin E; Vincic E; Jansson M; Blaxhult A; Gyllensten K; Moberg L; Broström C; Fenyö EM; Albert J
J Gen Virol; 2005 Dec; 86(Pt 12):3385-3396. PubMed ID: 16298986
[TBL] [Abstract][Full Text] [Related]
9. Increased adhesion as a mechanism of antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus infection.
Lund O; Hansen J; Søorensen AM; Mosekilde E; Nielsen JO; Hansen JE
J Virol; 1995 Apr; 69(4):2393-400. PubMed ID: 7884885
[TBL] [Abstract][Full Text] [Related]
10. Reconstitution and characterization of antibody repertoires of HIV-1-infected "elite neutralizers".
Sun Z; Li J; Hu X; Shao Y; Zhang MY
Antiviral Res; 2015 Jun; 118():1-9. PubMed ID: 25770672
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Cross-Clade Characterization of Antibody-Mediated Recognition, Complement-Mediated Lysis, and Cell-Mediated Cytotoxicity of HIV-1 Envelope-Specific Antibodies toward Eradication of the HIV-1 Reservoir.
Mujib S; Liu J; Rahman AKMN; Schwartz JA; Bonner P; Yue FY; Ostrowski MA
J Virol; 2017 Aug; 91(16):. PubMed ID: 28592534
[TBL] [Abstract][Full Text] [Related]
12. HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies.
Fouda GG; Yates NL; Pollara J; Shen X; Overman GR; Mahlokozera T; Wilks AB; Kang HH; Salazar-Gonzalez JF; Salazar MG; Kalilani L; Meshnick SR; Hahn BH; Shaw GM; Lovingood RV; Denny TN; Haynes B; Letvin NL; Ferrari G; Montefiori DC; Tomaras GD; Permar SR;
J Virol; 2011 Sep; 85(18):9555-67. PubMed ID: 21734046
[TBL] [Abstract][Full Text] [Related]
13. Evolution of cross-neutralizing antibodies and mapping epitope specificity in plasma of chronic HIV-1-infected antiretroviral therapy-naïve children from India.
Makhdoomi MA; Khan L; Kumar S; Aggarwal H; Singh R; Lodha R; Singla M; Das BK; Kabra SK; Luthra K
J Gen Virol; 2017 Jul; 98(7):1879-1891. PubMed ID: 28696188
[TBL] [Abstract][Full Text] [Related]
14. CRF01_AE-specific neutralizing activity observed in plasma derived from HIV-1-infected Thai patients residing in northern Thailand: comparison of neutralizing breadth and potency between plasma derived from rapid and slow progressors.
Sapsutthipas S; Tsuchiya N; Pathipavanich P; Ariyoshi K; Sawanpanyalert P; Takeda N; Isarangkura-na-ayuthaya P; Kameoka M
PLoS One; 2013; 8(1):e53920. PubMed ID: 23308290
[TBL] [Abstract][Full Text] [Related]
15. Analysis of neutralizing and enhancing antibodies to human immunodeficiency virus type 1 primary isolates in plasma of individuals infected with env Genetic subtype B and E viruses in Thailand.
Auewarakul P; Louisirirotchanakul S; Sutthent R; Taechowisan T; Kanoksinsombat C; Wasi C
Viral Immunol; 1996; 9(3):175-85. PubMed ID: 8890476
[TBL] [Abstract][Full Text] [Related]
16. Cross Type Neutralizing Antibodies Detected in a Unique HIV-2 Infected Individual From India.
Vidyavijayan KK; Cheedarala N; Babu H; Precilla LK; Sathyamurthi P; Chandrasekaran P; Murugavel KG; Swaminathan S; Tripathy SP; Hanna LE
Front Immunol; 2018; 9():2841. PubMed ID: 30619250
[No Abstract] [Full Text] [Related]
17. Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection.
Björling E; Scarlatti G; von Gegerfelt A; Albert J; Biberfeld G; Chiodi F; Norrby E; Fenyö EM
Virology; 1993 Mar; 193(1):528-30. PubMed ID: 8438591
[TBL] [Abstract][Full Text] [Related]
18. Evolution of Neutralization Response in HIV-1 Subtype C-Infected Individuals Exhibiting Broad Cross-Clade Neutralization of HIV-1 Strains.
Cheedarla N; Hemalatha B; Anangi B; Muthuramalingam K; Selvachithiram M; Sathyamurthi P; Kailasam N; Varadarajan R; Swaminathan S; Tripathy SP; Vaniambadi SK; Vadakkupattu DR; Hanna LE
Front Immunol; 2018; 9():618. PubMed ID: 29662494
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques.
Miller-Novak LK; Das J; Musich TA; Demberg T; Weiner JA; Venzon DJ; Mohanram V; Vargas-Inchaustegui DA; Tuero I; Ackerman ME; Alter G; Robert-Guroff M
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021899
[TBL] [Abstract][Full Text] [Related]
20. Broad and potent neutralizing antibody responses elicited in natural HIV-2 infection.
Kong R; Li H; Bibollet-Ruche F; Decker JM; Zheng NN; Gottlieb GS; Kiviat NB; Sow PS; Georgiev I; Hahn BH; Kwong PD; Robinson JE; Shaw GM
J Virol; 2012 Jan; 86(2):947-60. PubMed ID: 22031948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
